Former vice president Chen Chien-jen (陳建仁), an epidemiologist, earlier this year said that as the highly transmissible but less severe Omicron variant of SARS-CoV-2 became the world’s predominant strain of COVID-19, a “zero COVID” strategy is no longer practical, and people should be prepared to live with the virus. He said the “three treasures” preventing the healthcare system from being overwhelmed by severe cases and death are “vaccines, rapid tests and antiviral drugs.”
Taiwan in the past two years had implemented strict border control measures and domestic restrictions to prevent the spread of the virus in local communities. This helped buy time for the arrival and distribution of vaccines. However, as vaccine uptake slowed and daily cases began to surge, rapid test kits and antiviral drugs took on a more essential role.
The sudden demand last month for rapid tests, which at the time cost about NT$300 each, almost depleted the nation’s stocks. A rationing system was implemented on April 28 and the price was fixed at NT$500 for a pack of five. However, people still need to wait in lines at pharmacies to buy the limited supplies, which often run out before everyone can buy one. Taiwanese questioned whether the Central Epidemic Command Center (CECC) had made adequate preparations for the Omicron wave.
By Monday, the situation seemed to be addressed as single test kits were being sold at eight chain retail stores in northern Taiwan, but lines still formed outside pharmacies, and several industries are still in need of tests for their workers. Adding to the pressure, government-funded polymerase chain reaction (PCR) testing stations and emergency rooms have been crowded by people waiting for hours to be tested.
New Taipei City Mayor Hou You-yi (侯友宜) and Taipei Mayor Ko Wen-je (柯文哲) have repeatedly called for rapid test results to be enough to confirm a case, so that PCR testing would not stress healthcare capacity. Ko also urged for antiviral drugs to be prescribed to people whose rapid test show a positive result. The CECC partly agreed to their request by allowing people in quarantine or isolation to confirm their results with a doctor via a video call as of Thursday.
Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the CECC, on Friday said that there are legal and medical concerns, as rapid tests can produce false positive results. Prescribing antiviral drugs to people who falsely test positive for COVID-19 would be inappropriate and problematic.
Giving doctors the means to prescribe antiviral drugs accurately and efficiently to cases at higher risk of severe COVID-19 illness is a challenge for the government. Taipei has procured 700,000 courses of Paxlovid, the main COVID-19 oral antiviral drug, although fewer than 1,000 courses had been prescribed as of Monday.
The CECC in the past week has simplified prescription procedures and expanded channels for patients to receive Paxlovid faster — it needs to be taken within five days of the onset of symptoms. However, many people are having trouble booking a telemedicine appointment, and some are not meeting the government’s criteria for obtaining the drug.
Local infections are expected to reach their peak around the end of this month. The CECC and local governments must cooperate to improve the efficiency of COVID-19 testing and how Paxlovid gets prescribed. Keeping severe COVID-19 cases and deaths as low as possible is essential to safely riding out this wave of the pandemic.
The United States Agency for International Development (USAID) has long been a cornerstone of US foreign policy, advancing not only humanitarian aid but also the US’ strategic interests worldwide. The abrupt dismantling of USAID under US President Donald Trump ‘s administration represents a profound miscalculation with dire consequences for global influence, particularly in the Indo-Pacific. By withdrawing USAID’s presence, Washington is creating a vacuum that China is eager to fill, a shift that will directly weaken Taiwan’s international position while emboldening Beijing’s efforts to isolate Taipei. USAID has been a crucial player in countering China’s global expansion, particularly in regions where
US President Donald Trump has gotten off to a head-spinning start in his foreign policy. He has pressured Denmark to cede Greenland to the United States, threatened to take over the Panama Canal, urged Canada to become the 51st US state, unilaterally renamed the Gulf of Mexico to “the Gulf of America” and announced plans for the United States to annex and administer Gaza. He has imposed and then suspended 25 percent tariffs on Canada and Mexico for their roles in the flow of fentanyl into the United States, while at the same time increasing tariffs on China by 10
With the manipulations of the Chinese Nationalist Party (KMT) and the Taiwan People’s Party (TPP), it is no surprise that this year’s budget plan would make government operations difficult. The KMT and the TPP passing malicious legislation in the past year has caused public ire to accumulate, with the pressure about to erupt like a volcano. Civic groups have successively backed recall petition drives and public consensus has reached a fever-pitch, with no let up during the long Lunar New Year holiday. The ire has even breached the mindsets of former staunch KMT and TPP supporters. Most Taiwanese have vowed to use
Despite the steady modernization of the Chinese People’s Liberation Army (PLA), the international community is skeptical of its warfare capabilities. Late last month, US think tank RAND Corp published two reports revealing the PLA’s two greatest hurdles: personnel challenges and structural difficulties. The first RAND report, by Jennie W. Wenger, titled Factors Shaping the Future of China’s Military, analyzes the PLA’s obstacles with recruitment, stating that China has long been committed to attracting young talent from top universities to augment the PLA’s modernization needs. However, the plan has two major constraints: demographic changes and the adaptability of the PLA’s military culture.